Hillary St. John Ph.D.

Cystic Fibrosis Foundation Therapeutics

Hillary St. John, Ph.D., is a scientist in the Molecular Biology group at the Cystic Fibrosis Foundation Therapeutics (CFFT) Lab. At CFFT, Hillary is using gene editing technology to create model cell lines with specific patient mutations for use in drug screening and development efforts. Prior to joining CFFT, she earned a B.S. in Biology and Chemistry from St. Lawrence University and a Ph.D. in Biochemistry from the University of Wisconsin-Madison, which was followed by a postdoctoral position at Proteovista LLC.